KLOW peptide therapy isnt a one-size-fits-all solution, but it offers targeted support for a wide range of health goals
Animal acute toxicity studies across Sikiric's group publications have consistently shown a low acute toxicity profile, with no defined lethal dose identified in standard rodent models
doi: 10.1038/srep30033 (2016)
As a leading source, we provide a range of formulations to meet various research needs
Dual peptides for the treatment of obesity Tirzepatide, a novel dual GIP and GLP-1RA, offers significant insights into its mechanism of action, therapeutic benefits, and clinical applications for the management of T2D and obesity in general practice
It reduces appetite, helps control cravings, and increases calorie burn by modulating neurotransmitters in the brain